CONTEXT: The glucocorticoid receptor (GR) is a key hormone in the hypothalamus-pituitary-adrenal axis that regulates many pathways including blood pressure homeostasis. Thus, GR gene variation may influence interindividual differences in blood pressure in human populations. OBJECTIVE: We resequenced individual GR alleles for comprehensive discovery of GR variants and their chromosomal phase in three major American ethnic groups. We examined the influence of GR variants on blood pressure in large numbers of families using family-based association methods. DESIGN AND PARTICIPANTS: For association studies, we genotyped GR variants in family members from the Genetic Epidemiology Network of Arteriopathy (GENOA) study that were measured for multiple blood pressure traits. The GENOA families consisted of African-Americans, Mexican-Americans, and European-Americans. MAIN MEASUREMENTS: The blood pressure measurements for association studies included systolic blood pressure, diastolic blood pressure, mean arterial pressure, and pulse pressure. RESULTS: Single-nucleotide polymorphisms (SNPs) identified by resequencing were tested for associations with blood pressure measures in GENOA families. Analysis of individual SNPs identified significant associations of rs6198 A/G in exon 9beta with multiple blood pressure measures in European-Americans. Analysis of GR haplotypes found significant associations of a haplotype that is distinguished by rs6198 A/G. CONCLUSIONS: Significant associations of blood pressure with rs6198 A/G likely reflect allelic effects on GR signaling. This SNP disrupts a 3' untranslated region sequence element in exon 9beta that destabilizes mRNA, resulting in increased production of the inactive GRbeta isoform. Excess heterodimerization with the active GRalpha isoform may reduce GR signaling with subsequent physiological effects on blood pressure regulation.
CONTEXT: The glucocorticoid receptor (GR) is a key hormone in the hypothalamus-pituitary-adrenal axis that regulates many pathways including blood pressure homeostasis. Thus, GR gene variation may influence interindividual differences in blood pressure in human populations. OBJECTIVE: We resequenced individual GR alleles for comprehensive discovery of GR variants and their chromosomal phase in three major American ethnic groups. We examined the influence of GR variants on blood pressure in large numbers of families using family-based association methods. DESIGN AND PARTICIPANTS: For association studies, we genotyped GR variants in family members from the Genetic Epidemiology Network of Arteriopathy (GENOA) study that were measured for multiple blood pressure traits. The GENOA families consisted of African-Americans, Mexican-Americans, and European-Americans. MAIN MEASUREMENTS: The blood pressure measurements for association studies included systolic blood pressure, diastolic blood pressure, mean arterial pressure, and pulse pressure. RESULTS: Single-nucleotide polymorphisms (SNPs) identified by resequencing were tested for associations with blood pressure measures in GENOA families. Analysis of individual SNPs identified significant associations of rs6198 A/G in exon 9beta with multiple blood pressure measures in European-Americans. Analysis of GR haplotypes found significant associations of a haplotype that is distinguished by rs6198 A/G. CONCLUSIONS: Significant associations of blood pressure with rs6198 A/G likely reflect allelic effects on GR signaling. This SNP disrupts a 3' untranslated region sequence element in exon 9beta that destabilizes mRNA, resulting in increased production of the inactive GRbeta isoform. Excess heterodimerization with the active GRalpha isoform may reduce GR signaling with subsequent physiological effects on blood pressure regulation.
Authors: H Yan; N Papadopoulos; G Marra; C Perrera; J Jiricny; C R Boland; H T Lynch; R B Chadwick; A de la Chapelle; K Berg; J R Eshleman; W Yuan; S Markowitz; S J Laken; C Lengauer; K W Kinzler; B Vogelstein Journal: Nature Date: 2000-02-17 Impact factor: 49.962
Authors: T Wallerath; K Witte; S C Schäfer; P M Schwarz; W Prellwitz; P Wohlfart; H Kleinert; H A Lehr; B Lemmer; U Förstermann Journal: Proc Natl Acad Sci U S A Date: 1999-11-09 Impact factor: 11.205
Authors: R H Derijk; M J Schaaf; G Turner; N A Datson; E Vreugdenhil; J Cidlowski; E R de Kloet; P Emery; E M Sternberg; S D Detera-Wadleigh Journal: J Rheumatol Date: 2001-11 Impact factor: 4.666
Authors: Erica L T van den Akker; Jan W Koper; Elisabeth F C van Rossum; Marieke J H Dekker; Henk Russcher; Frank H de Jong; Andre G Uitterlinden; Albert Hofman; Huibert A Pols; Jacqueline C M Witteman; Steven W J Lamberts Journal: Arch Intern Med Date: 2008-01-14
Authors: Catherine P Walsh; Alvin Lim; Anna L Marsland; Robert E Ferrell; Stephen B Manuck Journal: Brain Behav Immun Date: 2019-01-11 Impact factor: 7.217
Authors: Nifang Niu; Venkatraman Manickam; Krishna R Kalari; Irene Moon; Linda L Pelleymounter; Bruce W Eckloff; Eric D Wieben; Daniel J Schaid; Liewei Wang Journal: J Clin Endocrinol Metab Date: 2009-05-12 Impact factor: 5.958
Authors: Patricia C Chulada; Enrikas Vainorius; Stavros Garantziotis; Lauranell H Burch; Perry J Blackshear; Darryl C Zeldin Journal: Environ Health Perspect Date: 2011-06-09 Impact factor: 9.031